Diabetes & Metabolism

Article	Citations
Contents - page 1	134
Analysis of glycemic control in diabetic patients by monitoring HbA1c levels before, during and after Covid-19 confinement in Auvergne, France	123
Diuretics and risk of major adverse limb events in patients with type-2 diabetes: An observational retrospective study	83
Editorial board	64
Discontinuation of hemodialysis after correction of a major hypothyroidism episode, A case report	45
Cost analysis of continuous glucose monitoring in patients hospitalized in a diabetes department	43
Are GLP-1 receptor agonists and diabetic retinopathy foes or friends?	36
Overview of the major clinical trials investigating stem cells–based therapies for diabetes	35
Factors impacting the recent doubling of French hyperglycaemia prevalence in pregnancy	34
Contents	33
Editorial board	31
Diabetic retinopathy remission in patients using an automated insulin delivery system: A prospective controlled study	29
Association between adipose deposition and mortality among adults without major cardiovascular risk factors	29
Pancreatic polypeptide in patients with type 1 diabetes and exocrine failure or chronic pancreatitis. The DIAPP study	28
Reduced risks of colorectal cancer with GLP-1RAs in type 2 diabetes: A nationwide cohort study using a target trial emulation framework	28
Management of dyslipidemia in adults. A consensus statement from the French Society of Endocrinology (SFE), the French-speaking Diabetes Society (SFD), the New French-speaking Atherosclerosis Society	27
Telemedicine-based diabetic retinopathy screening in patients over 70 Years: a French cohort study within the OPHDIAT network	27
Bedside amputation surgery for isolated toe necrosis in diabetes units as an alternative to conventional amputation in surgery units	26
Glucagon-like peptide-1 receptor agonists and the risk of nonarteritic anterior ischemic optic neuropathy: Evidence from a global real-world cohort	25
Prevalence and incidence of cardiovascular and renal diseases in type 1 compared with type 2 diabetes: A nationwide French observational study of hospitalized patients	24
The significance of ophthalmological evaluation in the correct diagnosis of pediatric insulin-dependent diabetes mellitus: lessons from novel WFS1 variants	24
Body weight trends in individuals with type 1 diabetes using automated insulin delivery vs. traditional insulin pumps	23
Editorial board	22
Obesity rather than diabetes impacted severe Covid-19 on reunion island: A retrospective cohort study from a frontline hospital, 2020–2021	21
Concise review of lipidomics in nonalcoholic fatty liver disease	21

Association between metabolic dysfunction-associated fatty liver disease and supraventricular and ventricular tachyarrhythmias in patients with type 2 diabetes	21
Cardiovascular protection significantly depends on HbA1c improvement with GLP-1RAs but not with SGLT2 is in type 2 diabetes: A narrative review	19
Eleven-year trends in socioeconomic inequalities in the prevalence and incidence of pharmacologically treated type 2 diabetes in France, 2010–2020	19
Contents	19
Screening strategies for glucose tolerance abnormalities and diabetes in people with cystic fibrosis	18
Mitochondrial heteroplasmy-phenotype correlation and response to glucose lowering therapy in subjects with m.3243A>G mutations	18
Modelled substitution of meat with dairy products and the 20-year cumulative incidence of type 2 diabetes: Insights from the ATTICA cohort study (2002–2022)	17
Contents	17
Prevent hypoglycaemia when using automated insulin delivery systems in type 1 diabetes requires near normal glycaemic variability	17
Musculoskeletal disorders in type 1 diabetes: Clinical phenotyping and associations with quality of life and glucose control - The French SFDT1 cohort study	17
Contents	17
Effects of SGLT2 inhibitors on clinical cancer survival in patients with type 2 diabetes	17
Type B insulin resistance syndrome: A case report	16
Prevalence of NAFLD, MAFLD, and MASLD: NHANES 1999-2018	16
1-h post-load plasma glucose for detecting early stages of prediabetes	16
No association between carbohydrate-counting knowledge and disordered eating behaviors in adults with type 1 diabetes	16
Methylamine metabolites and progression to kidney failure in type 2 diabetes: An Asian and European prospective study	15
Averaged glycaemic variability or by average: More than a simple question of wording	15
Effects of elexacaftor / tezacaftor / ivacaftor triple combination therapy on glycaemic control and body composition in patients with cystic fibrosis-related diabetes	14
Glucose management indicator: Do we need device-specific equations?	14
Correspondence for “Parental history of psychiatric disorders and risk of type 1 diabetes in the offspring”	14
Contents	14
Contents - Page 1	13
Efficacy and safety of pharmacological treatments for gestational diabetes: a systematic review comparing metformin with glibenclamide and insulin	13
Monitoring gestational diabetes mellitus patients with myDiabby Healthcare® smartphone application vs classical diary. Results from the non-inferiority TELESUR-GDM study	13
Editorial board	13
Editorial board	13
Conduction disturbances in Type 1 and Type 2 Diabetes in two large independent nationwide and international databases	12
Age-related difference in the impact of diabetes mellitus on all-cause mortality after acute myocardial infarction	12
Contents	12
Glucagon like peptide-1 receptor agonists in type 1 diabetes	12
Peripheral neuropathy as a bedside marker for cerebral microangiopathy	12
Postprandial glucose is correlated with an increasing risk of liver fibrosis in Chinese patients with nonalcoholic fatty liver disease	12
Glycemic Risk Index (GRI) variability in type 1 diabetes adults with HbA1c ≤ 7%: Insights for clinical evaluation and intervention	12
Effects of smoking behavior change on diabetes incidence after cancer development: A nationwide cohort study	12
Diabetes prevalence, awareness, and control in the United States, 2017-2023	12
Fracture risk and treatment thresholds in patients with diabetes	12
Editorial board	12
Contents - page 1	11
Reduction of circulating methylglyoxal levels by a Mediterranean diet is associated with preserved kidney function in patients with type 2 diabetes and coronary heart disease: From the CORDIOPREV rand	11
Association between different modalities of insulin administration and metabolic dysfunction-associated fatty liver disease in adults with type 1 diabetes mellitus	11
Perirenal fat and chronic kidney disease in type 2 diabetes: The mediation role of afferent arteriolar resistance	11
Acute kidney injury is associated with liver-related events in patients with metabolic dysfunction-associated fatty liver disease	11
"Usefulness of continuous interstitial glucose in diabetic patient undergoing hemodialysis	11
Real-world use and effectiveness of tirzepatide among people without evidence of type 2 diabetes in the United States	10
Trajectories of metabolic risk factors during the development of type 2 diabetes in Chinese adults	10
Effect of glucagon-like peptide 1 receptor agonists on the renal protection in patients with type 2 diabetes: A systematic review and meta-analysis	10
Contents	10
Editorial board	10
Effect of SGLT2 inhibitors versus DPP4 inhibitors on major and non-major osteoporotic fracture risks among general and high-risk type 2 diabetes patients: A nationwide retrospective cohort study	10

MASLD, hepatic steatosis and fibrosis are associated with the prevalence of chronic kidney disease and retinopathy in adults with type 1 diabetes mellitus	10
One-hour post-load glucose is associated with biopsy-proven metabolic dysfunction-associated steatotic liver disease in obese individuals	10
Association of podocyte ultrastructural changes with proteinuria and pathological classification in type 2 diabetic nephropathy	10
BMD: Toward mechanistically-informed and fracture-specific treatment thresholds in diabetic bone disease	10
Modification of the all-cause and cardiovascular disease related mortality risk with changes in the metabolic syndrome status: a population-based prospective cohort study in Taiwan	9
Global Burden of type 2 diabetes in non-elderly individuals 1990 to 2021 and projections for 2050: a systematic analysis of the 2021 Global Burden of Disease	9
Renoprotective mechanisms of glucagon-like peptide-1 receptor agonists	9
Is Omnipod 5 cost effective for the management of type 1 diabetes among adults in France?	9
Association between nonalcoholic fatty liver disease and left ventricular diastolic dysfunction: A 7-year retrospective cohort study of 3,380 adults using serial echocardiography	9
Secukinumab (Anti-IL-17) induces clinical regression in early diagnosed type 1 diabetes: A case report	9
Understanding the link between different types of maternal diabetes and the onset of autism spectrum disorders	9
Incidence of death and amputation in patients with a first diabetic foot ulcer: results from the CODIA cohort	9
Association between smoking status and suicide mortality in patients with type 2 diabetes: A nationwide population-based cohort study	9
Effect of dietary reinforcement combined or not with GLP-1 receptor agonist therapy on histological outcomes in MASLD among patients with type 2 diabetes	9
Impact of different types of hypertensive disorders of pregnancy and their duration on incident post-partum risk of diabetes mellitus: Results from the French nationwide study CONCEPTION	9
Editorial board	8
SGLT2 inhibitor and urothelial carcinoma incidence in type 2 diabetes patients	8
Short course corticosteroid treatment and closed-loop insulin delivery system: The experience of the DBLG1 pre-launch	8
Characteristics of newly diagnosed type 1 diabetes in paediatric and adult population from Reims University Hospital, France from 1997 to 2019	8
Automated insulin delivery for people living with Type 1 Diabetes in France: A long road ahead	8
Excess burden of hospitalizations in adults with diabetes – a national US cross-sectional study	8
Safety of sodium-glucose cotransporter 2 inhibitors in kidney transplant recipients with diabetes mellitus	8
Comparisons of the risks of new-onset prostate cancer in type 2 diabetes mellitus between SGLT2I and DPP4I users: A population-based cohort study	8
Risk of sepsis and pneumonia in patients initiated on SGLT2 inhibitors and DPP-4 inhibitors	8
Could the development of COVID-19 vaccine-induced type 1 diabetes be explained by a simple mechanism?	8
The impact of canagliflozin on the risk of neuropathy events: A post-hoc exploratory analysis of the CREDENCE trial	7
Treatment of women with mild gestational diabetes mellitus decreases the risk of adverse perinatal outcomes	7
Patient-reported outcome measures (PROMs) are differently associated with treatment modalities, household income, and diabetes-related events in children with type 1 diabetes, their mothers, and their	7
Serum albumin and risk of incident diabetes and diabetic microvascular complications in the UK Biobank cohort	7
Bone phenotype in familial partial lipodystrophy type 2: Insulin resistance and sclerostin	7
Trajectories of social isolation and loneliness and the risk of incident type 2 diabetes mellitus across genetic risk score	7
Reproductive factors, genetic susceptibility and risk of type 2 diabetes: A prospective cohort study	7
Do SGLT2 inhibitors and GLP-1 receptor agonists modulate differently the risk of stroke ? Discordance between randomised controlled trials and observational studies	7
Association of daily sleep duration with risk of metabolic dysfunction-associated steatotic liver disease and adverse liver outcomes	7
Contents	7
Impact of chronic emotions and psychosocial stress on glycemic control in patients with type 1 diabetes. Heterogeneity of glycemic responses, biological mechanisms, and personalized medical treatment	7
Metabolic dysfunction-associated fatty liver disease and risk of incident chronic kidney disease: A nationwide cohort study	7
Increased risk of renal events in people with diabetic foot disease: A longitudinal observational study	6
Glucose-lowering agents and risk of ventricular arrhythmias and sudden cardiac death: A comprehensive review ranging from sulphonylureas to SGLT2 inhibitors	6
Prevalence and risk of diabetic complications in young-onset versus late-onset type 2 diabetes mellitus	6
Exploring perceived barriers to physical activity among individuals with type 1 diabetes in the era of new technologies: An analysis from the BETTER registry	6
Do GLP1-receptor agonists actually cause non-arteritic anterior ischemic optic neuropathy?	6
Association between diabetes and stress-induced hyperglycemia with skeletal muscle gene expression of INSR in critically ill patients: A prospective cohort study	6
Risks of carpal tunnel syndrome and carpal tunnel release surgery in users of sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide-1 receptor agonists: A target trial emulation study	6
Glucagon-like peptide 1 receptor agonists and renal outcomes in kidney transplant recipients with diabetes mellitus	6
Incidence of new-onset type 1 diabetes during Covid-19 pandemic: A French nationwide population-based study	6
GLP-1-derived therapies and sarcopenia: plea for a specific focus on at risk special populations	6
Post-translational modifications of apolipoproteins as promising biomarkers for diabetes-related cardiovascular diseases: A comprehensive review	6
Ketoacidosis associated with type 2 sodium-glucose cotransporter inhibitors (SGLT2i) in patients aged 65 and older: Evidence from the French national pharmacovigilance database	5
Parental history of psychiatric disorders and risk of type 1 diabetes in the offspring	5
Low hemoglobin, even within the normal range, is associated with diabetic kidney disease	5
Editorial board	5
Leisure-time physical activity and mortality risk in type 2 diabetes: A nationwide cohort study	5
Association between blood urea nitrogen-to-creatinine ratio and insulin sensitivity	5
Impaired auditory neural performance, another dimension of hearing loss in type-2 diabetes mellitus	5
Non-dioxin-like polychlorinated biphenyls (NDL-PCBs) dietary exposure is associated with an increased risk of type 2 diabetes in the European prospective investigation into cancer and nutrition (EPIC)	5
When “good” comes too fast: rapid glycemic correction and the kidney: a “metabolic descent” hypothesis	5
Phthalates exposure, biological aging, and increased risks of insulin resistance, prediabetes, and diabetes in adults with metabolic dysfunction-associated steatotic liver disease	5
A very rare cause of markedly elevated CA 19–9: Glucagon-like peptide-1 receptor agonists	5
Lipoatrophic diabetes in familial partial lipodystrophy type 2: From insulin resistance to diabetes	5
The association between primary bile acids and metabolically unhealthy obesity	5
High Intensity Interval Training reduces hypoglycemic events compared with continuous aerobic training in individuals with type 1 diabetes	4
Editorial board	4
Closed-loop insulin delivery systems in patients with pancreatitis or pancreatectomy-induced diabetes: A case series	4
Epicardial adipose tissue measurement is an interesting biomarker for cardiovascular health in a case control study of patients with familial partial type 2 lipodystrophy	4
Microalbuminuria screening in patients with ST-elevation myocardial infarction	4
Contents	4
Skin autofluorescence of advanced glycation end-products relates to new cardiovascular events in type 2 diabetes: A longitudinal observational study	4
β-hydroxybutyrate as a biomarker of β-cell function in new-onset type 2 diabetes and its association with treatment response at 6 months	4
Editorial board	4
Persistent gaps in the implementation of lipid-lowering therapy in patients with established atherosclerotic cardiovascular disease: A French nationwide study	4
Addition of fenofibrate to statins is associated with risk reduction of diabetic retinopathy progression in patients with type 2 diabetes and metabolic syndrome: A propensity-matched cohort study	4
Relationship of ultra-processed food consumption and new-onset chronic kidney diseases among participants with or without diabetes	4
Association between gastrectomy and the risk of type 2 diabetes in gastric cancer survivors: A nationwide cohort study	4
Risk of rotator cuff tear and rotator cuff repair surgery comparison between sodium-glucose cotransporter 2 inhibitors and glucagon like peptide-1 receptor agonists: A real-world study	4
Comment on Orsi et al. Retinopathy as an independent predictor of all-cause mortality in individuals with type 2 diabetes [Diabetes Metab, 2023 Mar, 101413]	4
Glucagon-like peptide-1 receptor agonists and acute pancreatitis	4
Comparative cardiovascular effectiveness of GLP-1RAs versus DPP-4is in dialysis patients with type 2 diabetes: a target trial emulation	4
Editorial board	4
Editorial board	4

Regular use of ibuprofen or paracetamol and incident type 2 diabetes: A prospective cohort study in the UK Biobank	3
Circulating levels of GDF-15 for predicting cardiovascular and cancer morbidity and mortality in type 2 diabetes: Findings from Da Qing IGT and Diabetes Study	3
The association of sweetened beverage intake with risk of type 2 diabetes in an Australian population: A longitudinal study	3
Prediction of cardiovascular events by skin auto-fluorescence: the DIABAGE follow-up study	3
Comparative effectiveness of SGLT2 inhibitors and GLP-1 receptor agonists in preventing Alzheimer's disease, vascular dementia, and other dementia types among patients with type 2 diabetes	3
Equivalent fracture odds do not define equivalent treatment thresholds in diabetes	3
Glycemic and renal effects of SGLT2 Inhibitors in Prader-Willi syndrome: Benefits and risks	3
Management of patients with type 2 diabetes and MASLD: An overview and joint statement	3
Elevation of hemoglobin A1c increases the risk of decline in left ventricular systolic function among patients with coronary artery disease	3
Management of diabetes in patients hospitalized for acute cardiac events: Joint position paper from the French Society of Cardiology and the French-speaking Diabetes Society	3
Plasma level of ATPase inhibitory factor 1 (IF1) is associated with type 2 diabetes risk in humans: A prospective cohort study	3
Early varicella infection is associated with a delayed onset of childhood type 1 diabetes	3
Cardiovascular and renal effects of the combination therapy of a GLP-1 receptor agonist and an SGLT2 inhibitor in observational real-life studies	3
Gut-muscle communication links FGF19 levels to the loss of lean muscle mass following rapid weight loss	3
Hip fractures and type 2 diabetes in the elderly: Risk factors analysis of the Nedices cohort	3
Key indices of glycaemic variability for application in diabetes clinical practice	3